Gemfibrozil
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2327 publications
Effectiveness, toxicity and treatment adjustments of lenvatinib plus pembrolizumab in advanced renal cell carcinoma: a multicenter real-world analysis.
Journal: ESMO real world data and digital oncology
Published: February 06, 2026
Adverse event profiles of fenofibrate and gemfibrozil: a retrospective comparative study and literature synthesis.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: January 13, 2026
Ni-Catalyzed Asymmetric Reductive Arylation and Alkenylation of N-Sulfonyl Imines.
Journal: Organic letters
Published: January 02, 2026
Estimating the impact of patient-level risk factors and time-varying hospital unit on healthcare-associated Clostridioides difficile infection using cross-classified multilevel models.
Journal: Infection control and hospital epidemiology
Published: December 01, 2025
Roles of Peroxisome Proliferator-Activated Receptors (PPARs) in Pancreatic Metabolic Diseases.
Journal: Pharmacological research
Published: November 28, 2025
Drug-drug interaction by metabolites: Challenges and solutions during therapeutics innovation.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: November 27, 2025
Seasonal and spatial dynamics of organic micropollutants in a Mediterranean river: implications for environmental risk assessment.
Journal: Environmental geochemistry and health
Published: October 16, 2025
Combined impacts of a lipid lowering drug, gemfibrozil, and temperature on bioenergetics and digestive gland function of a marine bivalve Mytilus edulis.
Journal: Aquatic toxicology (Amsterdam, Netherlands)
Published: October 13, 2025
Gemfibrozil Prevents Myocardial Ischemia-Reperfusion Injury in Mice Through AMPK Activation.
Journal: Clinical and experimental pharmacology & physiology
Published: September 18, 2025
Not all fibrates are made equal: Learning from biology and clinical trials.
Journal: Atherosclerosis
Published: September 18, 2025
Degradation of Typical PPCPs During Anaerobic Digestion and in Soil.
Journal: Toxics
Published: August 18, 2025
Bezafibrate, a Pan PPAR agonist, attenuates experimental rheumatoid arthritis via PPAR dependent modulation of inflammatory pathways with emphasis on PPAR γ activity.
Journal: International immunopharmacology
Published: August 06, 2025
Last Updated: 04/28/2026